The European antitrust regulators, on Wednesday, slapped a fine of 146 million euro on nine pharma companies, including Ranbaxy Laboratories, for blocking the market entry of cheaper generic versions of Danish company Lundbeck’s branded citalopram, a blockbuster anti-depressant. While, the European Commission fined euro 93.8 million on Danish pharmaceutical company Lundbeck, a fine of euro 10.32 million was imposed on Ranbaxy Laboratories.
The penalty follows a 2009 report by the European Commission on the pharmaceutical sector, which pointed at 'pay-for-delay' agreements between companies, leading to consumers paying as much as 20 percent more for their medicines. Pay-for-delay agreements involve brand-name firms paying generic companies not to market rival versions of their medicine. These agreements violated the EU antitrust rules that prohibit anticompetitive agreements (Article 101 of the Treaty on the Functioning of the European Union -TFEU).
Further, country’s largest pharmaceutical company, Ranbaxy now plans to appeal to the EU General Court in Luxembourg, Europe's second-highest, after being fined 10.3 million euros.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1834.40 |
| Dr. Reddys Lab | 1306.80 |
| Cipla | 1362.85 |
| Zydus Lifesciences | 940.10 |
| Lupin | 2459.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: